Giant cell arteritis mimicking fever of unknown origin: Potential diagnostic role of PET scan

Thrombosis and Haemostasis

Volumn 95, Issue 2, 2006, Pages 390-392

  Chavaillaz, Olivier ^a   Gueddi, Salah ^a   Taylor, Sophia ^a   Stalder, Hans ^a   Righini, Marc ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; FLUORODEOXYGLUCOSE F 18; PREDNISONE;

ADULT; ANOREXIA; ARTICLE; ASTHENIA; BODY WEIGHT DISORDER; CASE REPORT; CAUCASIAN; CLINICAL EXAMINATION; CLINICAL FEATURE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE DURATION; FEMALE; GIANT CELL ARTERITIS; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; INFLAMMATION; LABORATORY TEST; NECROTIZING ARTERITIS; PRIORITY JOURNAL; PYREXIA IDIOPATHICA; RADIODIAGNOSIS; RECURRENT DISEASE; SWEATING; TEMPORAL ARTERITIS; THORAX RADIOGRAPHY; THROMBOCYTOSIS; ULTRASOUND; UNSPECIFIED SIDE EFFECT; URINALYSIS; VAGINA DISCHARGE;

EID: 33645553062     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1612651     Document Type: Article

References (17)

1. Hunder GG, Bloch DA, Michel BA, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990; 33: 1122-8.
2. Achkar AA, Lie JT, Hunder GG, et al. How does previous corticosteroid treatment affect the biopsy findings in giant cell (temporal) arteritis? Arch Intern Med 1994; 120: 987-92.
3. Chmelewski WL, Mc Knight KM, Agudelo CA, et al. Presenting features and outcomes in patients undergoing temporal artery biopsy. Arch Intern Med 1992; 120: 1690-5.
4. Ray-Chaudhuri N, Kine DA, Tijani SO, et al. Effects of prior steroid treatment on temporal artery biopsy findings in giant cell arteritis. Br J Ophthalmol 2002; 86: 530-2.
5. Levine SM, Hellmann DB. Giant cell arteritis. Curr Opin Rheumatol 2002; 14: 3-10.
6. Meller J, Strutz F, Siefker U, et al. Early diagnosis and follow-up of aortitis with [(18)F]FDG PET and MRI. Eur J Nucl Med Mol Imaging 2003; 30: 730-6.
7. Klein RG, Hunder GG, Stanson AW, et al. Large artery involvement in giant cell (temporal) arteritis. Ann Intern Med 1975; 83: 806-12.
8. Nordborg E, Nordborg C. Giant cell arteritis: strategies in diagnosis and treatment. Curr Opin Rheumatol 2004; 16: 25-30.
9. Bar-Shalom R, Valdivia AY, Blaufox MD. PET imaging in oncology. Semin Nucl Med 2000; 30: 150-85.
10. Zhuang H, Yu JQ, Alavi A. Applications of fluorodeoxyglucose-PET imaging in the detection of infection and inflammation and other benign disorders. Radiol Clin North Am 2005; 43: 121-34.
11. Bleeker-Rovers CP, de Kleijn EM, Corstens FH, et al. Clinical value of FDG PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation. Eur J Nucl Med Mol Imaging 2004; 31: 29-37.
12. Blockmans D, Knockaert D, Maes A, et al. Clinical value of [(18)F]fluoro-deoxyglucose positron emission tomography for patients with fever of unknown origin. Clin Infect Dis 2001; 32: 191-6.
13. Brodmann M, Passath A, Aigner R, et al. F18-FDG-PET as a helpful tool in the diagnosis of giant cell arteritis. Rheumatology (Oxford) 2003; 42: 1264-6.
14. Schmidt WA, Blockmans D. Use of ultrasonography and positron emission tomography in the diagnosis and assessment of large-vessel vasculitis. Curr Opin Rheumatol 2004; 17: 9-15.
15. Brodmann M, Lipp RW, Passath A, et al. The role of 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography in the diagnosis of giant cell arteritis of the temporal arteries. Rheumatology (Oxford) 2004; 43: 241-2.
16. Karassa FB, Matsagas MI, Schmidt WA, et al. Meta-analysis: test performance of ultrasonography for giant-cell arteritis. Ann Intern Med 2005; 142: 359-69.
17. Blockmans D, Stroobants S, Maes A, et al. Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch. Am J Med 2000; 108: 246-9.